https://biotechmorning.com/news/tenax-tnx-103-level-trial-subgroup-esc-2026 Biotech Morning en 2026-08-30T14:13:24.989Z Tenax's Big Bet Walked 3.5 Meters. Then It Got Interesting. https://biotechmorning.com/news/gene-therapy-biggest-swing-heart-failure Biotech Morning en 2026-08-30T14:12:40.558Z Gene Therapy Just Took Its Biggest Swing at Heart Failure https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys-3 Biotech Morning en 2026-08-30T14:11:51.086Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a $900M Drug in Trouble https://biotechmorning.com/news/ausperbio-120m-series-c-hepatitis-b-cure Biotech Morning en 2026-08-30T14:11:03.552Z Someone Thinks Hepatitis B Can Finally Be Cured https://biotechmorning.com/news/teva-bioxcel-bankruptcy-cns-deal Biotech Morning en 2026-08-30T14:10:16.664Z Teva Goes Dumpster Diving for a $145M Brain Drug https://biotechmorning.com/news/roivant-first-pill-dermatomyositis-fda-approval Biotech Morning en 2026-08-30T14:09:29.511Z The First Pill for a Disease That Eats Your Muscles and Skin https://biotechmorning.com/news/camzyos-five-year-data-esc-2026 Biotech Morning en 2026-08-30T14:08:46.549Z Five Years on One Heart Drug. Here's What Happened. https://biotechmorning.com/news/bayer-evuzamitide-cardiac-amyloidosis-pet-diagnostic Biotech Morning en 2026-08-30T14:07:59.784Z Bayer Just Found a Way to Photograph Your Heart's Worst Secret https://biotechmorning.com/news/stargardt-disease-first-treatment-tinlarebant-2 Biotech Morning en 2026-08-30T14:07:10.252Z The Eye Disease With Zero Treatments Just Got Its First Real Shot https://biotechmorning.com/news/teva-bioxcel-igalmi-bankruptcy-bid Biotech Morning en 2026-08-29T14:19:05.606Z Teva's $57.5M Bargain Hunt in Biotech's Graveyard https://biotechmorning.com/news/mounjaro-cardiovascular-approval-glp1-race Biotech Morning en 2026-08-29T14:18:19.420Z Mounjaro Just Got a Promotion. Novo Nordisk Should Be Nervous. https://biotechmorning.com/news/astrazeneca-cardio-ttransform-rna-silencer-flop Biotech Morning en 2026-08-29T14:17:32.504Z The Heart Drug That Worked on Paper but Flopped Where It Counted https://biotechmorning.com/news/mimrylo-rusfertide-fda-approval-polycythemia-vera Biotech Morning en 2026-08-29T14:16:43.336Z The Drug That Could Make Blood Draws Obsolete for Thousands https://biotechmorning.com/news/cancer-vaccine-that-made-things-worse Biotech Morning en 2026-08-29T14:16:02.275Z The Cancer Vaccine That Made Things Worse https://biotechmorning.com/news/shingrix-cardiovascular-benefit-oxford-study Biotech Morning en 2026-08-29T14:14:59.743Z A Shingles Vaccine That Protects Your Heart? Oxford Says Maybe https://biotechmorning.com/news/aficamten-non-obstructive-hcm-acacia-trial Biotech Morning en 2026-08-29T14:14:14.055Z The Heart Drug That Just Crashed a Party It Wasn't Invited To https://biotechmorning.com/news/one-shot-rewrite-cholesterol-forever Biotech Morning en 2026-08-29T14:13:29.025Z One Shot to Rewrite Your Cholesterol Forever https://biotechmorning.com/news/moderna-2-6-billion-bet-mrna-cancer Biotech Morning en 2026-08-29T14:12:46.410Z Moderna Just Bet $2.6 Billion That mRNA Can Kill Cancer